Jacob Ricca

1.6k total citations
12 papers, 933 citations indexed

About

Jacob Ricca is a scholar working on Oncology, Genetics and Immunology. According to data from OpenAlex, Jacob Ricca has authored 12 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Genetics and 6 papers in Immunology. Recurrent topics in Jacob Ricca's work include Virus-based gene therapy research (6 papers), CAR-T cell therapy research (6 papers) and Immunotherapy and Immune Responses (3 papers). Jacob Ricca is often cited by papers focused on Virus-based gene therapy research (6 papers), CAR-T cell therapy research (6 papers) and Immunotherapy and Immune Responses (3 papers). Jacob Ricca collaborates with scholars based in United States and United Kingdom. Jacob Ricca's co-authors include Taha Merghoub, Dmitriy Zamarin, Jedd D. Wolchok, Tyler Walther, Anton Oseledchyk, Hebert Alberto Vargas, Jason Konner, Alejandro Jiménez-Sánchez, Stephane Pourpe and Oliver Zivanovic and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Jacob Ricca

12 papers receiving 913 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacob Ricca United States 8 583 392 340 297 100 12 933
Carter T. Fields United States 9 811 1.4× 257 0.7× 403 1.2× 483 1.6× 103 1.0× 17 1.4k
Jean‐Marc Limacher France 19 767 1.3× 482 1.2× 381 1.1× 583 2.0× 159 1.6× 44 1.4k
Annette Arnold Germany 12 522 0.9× 827 2.1× 198 0.6× 262 0.9× 132 1.3× 17 1.2k
Drew C. Deniger United States 14 874 1.5× 737 1.9× 166 0.5× 302 1.0× 87 0.9× 18 1.2k
Franziska Blaeschke Germany 18 832 1.4× 449 1.1× 288 0.8× 658 2.2× 163 1.6× 33 1.4k
Nahoko Suzuki Japan 8 393 0.7× 505 1.3× 124 0.4× 382 1.3× 56 0.6× 11 1.1k
Kathleen M. Haines United States 10 722 1.2× 394 1.0× 253 0.7× 338 1.1× 104 1.0× 15 1.1k
Pin-Yi Wang United States 14 331 0.6× 257 0.7× 327 1.0× 258 0.9× 101 1.0× 32 792
Gail DeRaffele United States 12 785 1.3× 624 1.6× 392 1.2× 336 1.1× 97 1.0× 19 1.1k
Elixabet Bolaños Spain 19 887 1.5× 972 2.5× 146 0.4× 290 1.0× 59 0.6× 33 1.4k

Countries citing papers authored by Jacob Ricca

Since Specialization
Citations

This map shows the geographic impact of Jacob Ricca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Ricca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Ricca more than expected).

Fields of papers citing papers by Jacob Ricca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Ricca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Ricca. The network helps show where Jacob Ricca may publish in the future.

Co-authorship network of co-authors of Jacob Ricca

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Ricca. A scholar is included among the top collaborators of Jacob Ricca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Ricca. Jacob Ricca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Ricca, Jacob, Anton Oseledchyk, Tyler Walther, et al.. (2018). Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy. Molecular Therapy. 26(4). 1008–1019. 111 indexed citations
2.
Zamarin, Dmitriy, Jacob Ricca, Svetlana Sadekova, et al.. (2018). PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy. Journal of Clinical Investigation. 128(4). 1413–1428. 120 indexed citations
3.
Ricca, Jacob, Anton Oseledchyk, Levi Mangarin, et al.. (2018). Pre-Existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy. SSRN Electronic Journal. 1 indexed citations
4.
Hirschhorn, Daniel, Jacob Ricca, Billel Gasmi, et al.. (2018). A delicate interplay between adaptive and innate immunity caused by immunotherapy triggers tumor immunity and aseptic inflammation. The Journal of Immunology. 200(Supplement_1). 178.42–178.42. 4 indexed citations
5.
Oseledchyk, Anton, Jacob Ricca, Mathieu Gigoux, et al.. (2018). Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus. Oncotarget. 9(47). 28702–28716. 27 indexed citations
6.
Zamarin, Dmitriy, Rikke Holmgaard, Jacob Ricca, et al.. (2017). Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity. Nature Communications. 8(1). 14340–14340. 111 indexed citations
7.
Ricca, Jacob, Mesruh Turkekul, Afşar Barlas, et al.. (2017). Validation of Anti-Mouse PDL-1 Goat Polyclonal Antibody Staining with Mouse PDL-1 In Situ Hybridization on Adjacent Sections of Cell Pellets and Mouse Tumors. Methods in molecular biology. 1554. 253–262. 1 indexed citations
8.
Jiménez-Sánchez, Alejandro, Danish Memon, Stephane Pourpe, et al.. (2017). Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient. Cell. 170(5). 927–938.e20. 334 indexed citations
9.
10.
Jelinic, Petar, Jacob Ricca, Narciso Olvera, et al.. (2017). Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade. JNCI Journal of the National Cancer Institute. 110(7). 787–790. 107 indexed citations
11.
Serrano, Antonio, et al.. (2016). A Multifaceted Role for Myd88-Dependent Signaling in Progression of Murine Mammary Carcinoma. Breast Cancer Basic and Clinical Research. 10. BCBCR.S40075–BCBCR.S40075. 3 indexed citations
12.
Chalmers, Samantha A., et al.. (2013). A role for HMGB1, HSP60 and Myd88 in growth of murine mammary carcinoma in vitro. Cellular Immunology. 282(2). 136–145. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carter T. Fields Breakdown of academic impact, for papers by Jean‐Marc Limacher Breakdown of academic impact, for papers by Annette Arnold Breakdown of academic impact, for papers by Drew C. Deniger Breakdown of academic impact, for papers by Franziska Blaeschke Breakdown of academic impact, for papers by Nahoko Suzuki Breakdown of academic impact, for papers by Kathleen M. Haines Breakdown of academic impact, for papers by Pin-Yi Wang Breakdown of academic impact, for papers by Gail DeRaffele Breakdown of academic impact, for papers by Elixabet Bolaños
Rankless by CCL
2026